Skip survey header

Novo Nordisk Product Theater SBHPP 2025

1. I am a(n):
ACTIONS

1=Strongly Disagree, 4=Neutral, 7=Strongly Agree.
* Required Field.
2. As a result of this program, I intend to:
Reevaluate this therapy to help achieve cardiorenal and A1C goals for my appropriate patients with T2D with CKD and/or CVD.
*This question is required.
1234567Not applicable
3. As a result of this program, I intend to:
Initiate my appropriate adult patients with T2D with or without CKD and/or CVD on this therapy.
*This question is required.
1234567Not applicable
OBJECTIVES

1=Strongly Disagree, 4=Neutral, 7=Strongly Agree.
* Required Field.
4. As a result of this program, I am better able to:
Understand the clinical trial overviews and the efficacy and safety results of this therapy.
*This question is required.
1234567Not applicable
5. As a result of this program, I am better able to:
Understand the dosing recommendations for this therapy for my appropriate adult patients with T2D with or without CKD and/or CVD.
*This question is required.
1234567Not applicable
PRESENTATION

1=Strongly Disagree, 4=Neutral, 7=Strongly Agree.
* Required Field.
6. The speaker delivered the presentation clearly and effectively. *This question is required.
1234567Not applicable
7. The speaker was knowledgeable about the content. *This question is required.
1234567Not applicable
OVERALL

1=Strongly Disagree, 4=Neutral, 7=Strongly Agree.
* Required Field.
8. Please rate your overall satisfaction with this program. *This question is required.
1234567Not applicable